- Home
- AVTR vs QGEN Comparison
AVTR vs QGEN Comparison
Compare AVTR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTR
- QGEN
- Stock Information
- Founded
- AVTR 1904
- QGEN 1986
- Country
- AVTR United States
- QGEN Netherlands
- Employees
- AVTR N/A
- QGEN N/A
- Industry
- AVTR Biotechnology: Laboratory Analytical Instruments
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVTR Industrials
- QGEN Health Care
- Exchange
- AVTR Nasdaq
- QGEN Nasdaq
- Market Cap
- AVTR 9.4B
- QGEN 10.3B
- IPO Year
- AVTR 2019
- QGEN 1996
- Fundamental
- Price
- AVTR $12.31
- QGEN $45.29
- Analyst Decision
- AVTR Buy
- QGEN Buy
- Analyst Count
- AVTR 13
- QGEN 8
- Target Price
- AVTR $16.54
- QGEN $51.01
- AVG Volume (30 Days)
- AVTR 11.2M
- QGEN 1.4M
- Earning Date
- AVTR 10-24-2025
- QGEN 11-05-2025
- Dividend Yield
- AVTR N/A
- QGEN 3.33%
- EPS Growth
- AVTR 94.25
- QGEN 405.09
- EPS
- AVTR 1.01
- QGEN 1.69
- Revenue
- AVTR $6,665,800,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- AVTR N/A
- QGEN $7.22
- Revenue Next Year
- AVTR $2.34
- QGEN $5.66
- P/E Ratio
- AVTR $12.18
- QGEN $27.20
- Revenue Growth
- AVTR N/A
- QGEN 5.15
- 52 Week Low
- AVTR $10.83
- QGEN $37.63
- 52 Week High
- AVTR $27.83
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- AVTR 42.19
- QGEN 33.28
- Support Level
- AVTR $12.61
- QGEN $46.27
- Resistance Level
- AVTR $13.04
- QGEN $47.93
- Average True Range (ATR)
- AVTR 0.45
- QGEN 0.76
- MACD
- AVTR -0.07
- QGEN -0.22
- Stochastic Oscillator
- AVTR 0.59
- QGEN 0.00
About AVTR Avantor Inc.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).